10.1056/NEJMoa2301972 Jastreboff AM, Kaplan LM, Frías JP et al (2023) Triple-hormone-receptor agonist retatrutide for obesity—A Phase 2 Trial. The gene discussed is NR4A1; the disease is obesity disorder.